Dexamethasone and nitric oxide synthase gene expression in brain

Eiji Suzuki, Futoshi Shintani, Toshio Nakaki, Kiyoshi Nagata, Yasushi Yamazoe, Nobuchika Fujita, Masahiro Asai, Shigenobu Kanba

研究成果: ジャーナルへの寄稿記事

10 引用 (Scopus)

抄録

Systemic administration of lipopolysaccharide (LPS), which causes endotoxemia and systemic inflammation, has been reported to induce expression of the gene for type II inducible nitric oxide synthase (iNOS) in peripheral organs. This study was carried out to examine whether intraperitoneally injected LPS elicits the expression of iNOS messenger ribonucleic acid (mRNA) in the rat brain. We also investigated whether intraperitoneal treatment with dexamethasone (DEX) prevents this induction. To determine levels of iNOS mRNA, a quantitative reverse transcription-polymerase chain reaction (RT-PCR) method was employed. Treatment with LPS induced the expression of iNOS mRNA in various brain regions, accounting for approximately 1 x 105 to 4 x 105 molecules per μg of poly A+ RNA, and these inductions were markedly suppressed by DEX. The results suggest that, during systemic inflammation, iNOS mRNA induction occurs in brain through a DEX-sensitive mechanism.

元の言語英語
ページ(範囲)105-110
ページ数6
ジャーナルJournal of Psychiatry and Neuroscience
22
発行部数2
出版物ステータス出版済み - 5 28 1997
外部発表Yes

Fingerprint

Nitric Oxide Synthase Type II
Nitric Oxide Synthase
Dexamethasone
Gene Expression
RNA
Brain
Lipopolysaccharides
Inflammation
Endotoxemia
Reverse Transcription
Polymerase Chain Reaction
Messenger RNA

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Pharmacology (medical)

これを引用

Suzuki, E., Shintani, F., Nakaki, T., Nagata, K., Yamazoe, Y., Fujita, N., ... Kanba, S. (1997). Dexamethasone and nitric oxide synthase gene expression in brain. Journal of Psychiatry and Neuroscience, 22(2), 105-110.

Dexamethasone and nitric oxide synthase gene expression in brain. / Suzuki, Eiji; Shintani, Futoshi; Nakaki, Toshio; Nagata, Kiyoshi; Yamazoe, Yasushi; Fujita, Nobuchika; Asai, Masahiro; Kanba, Shigenobu.

:: Journal of Psychiatry and Neuroscience, 巻 22, 番号 2, 28.05.1997, p. 105-110.

研究成果: ジャーナルへの寄稿記事

Suzuki, E, Shintani, F, Nakaki, T, Nagata, K, Yamazoe, Y, Fujita, N, Asai, M & Kanba, S 1997, 'Dexamethasone and nitric oxide synthase gene expression in brain', Journal of Psychiatry and Neuroscience, 巻. 22, 番号 2, pp. 105-110.
Suzuki E, Shintani F, Nakaki T, Nagata K, Yamazoe Y, Fujita N その他. Dexamethasone and nitric oxide synthase gene expression in brain. Journal of Psychiatry and Neuroscience. 1997 5 28;22(2):105-110.
Suzuki, Eiji ; Shintani, Futoshi ; Nakaki, Toshio ; Nagata, Kiyoshi ; Yamazoe, Yasushi ; Fujita, Nobuchika ; Asai, Masahiro ; Kanba, Shigenobu. / Dexamethasone and nitric oxide synthase gene expression in brain. :: Journal of Psychiatry and Neuroscience. 1997 ; 巻 22, 番号 2. pp. 105-110.
@article{f124033c1b394869a243a5b729ca8b75,
title = "Dexamethasone and nitric oxide synthase gene expression in brain",
abstract = "Systemic administration of lipopolysaccharide (LPS), which causes endotoxemia and systemic inflammation, has been reported to induce expression of the gene for type II inducible nitric oxide synthase (iNOS) in peripheral organs. This study was carried out to examine whether intraperitoneally injected LPS elicits the expression of iNOS messenger ribonucleic acid (mRNA) in the rat brain. We also investigated whether intraperitoneal treatment with dexamethasone (DEX) prevents this induction. To determine levels of iNOS mRNA, a quantitative reverse transcription-polymerase chain reaction (RT-PCR) method was employed. Treatment with LPS induced the expression of iNOS mRNA in various brain regions, accounting for approximately 1 x 105 to 4 x 105 molecules per μg of poly A+ RNA, and these inductions were markedly suppressed by DEX. The results suggest that, during systemic inflammation, iNOS mRNA induction occurs in brain through a DEX-sensitive mechanism.",
author = "Eiji Suzuki and Futoshi Shintani and Toshio Nakaki and Kiyoshi Nagata and Yasushi Yamazoe and Nobuchika Fujita and Masahiro Asai and Shigenobu Kanba",
year = "1997",
month = "5",
day = "28",
language = "English",
volume = "22",
pages = "105--110",
journal = "Journal of Psychiatry and Neuroscience",
issn = "1180-4882",
publisher = "Canadian Medical Association",
number = "2",

}

TY - JOUR

T1 - Dexamethasone and nitric oxide synthase gene expression in brain

AU - Suzuki, Eiji

AU - Shintani, Futoshi

AU - Nakaki, Toshio

AU - Nagata, Kiyoshi

AU - Yamazoe, Yasushi

AU - Fujita, Nobuchika

AU - Asai, Masahiro

AU - Kanba, Shigenobu

PY - 1997/5/28

Y1 - 1997/5/28

N2 - Systemic administration of lipopolysaccharide (LPS), which causes endotoxemia and systemic inflammation, has been reported to induce expression of the gene for type II inducible nitric oxide synthase (iNOS) in peripheral organs. This study was carried out to examine whether intraperitoneally injected LPS elicits the expression of iNOS messenger ribonucleic acid (mRNA) in the rat brain. We also investigated whether intraperitoneal treatment with dexamethasone (DEX) prevents this induction. To determine levels of iNOS mRNA, a quantitative reverse transcription-polymerase chain reaction (RT-PCR) method was employed. Treatment with LPS induced the expression of iNOS mRNA in various brain regions, accounting for approximately 1 x 105 to 4 x 105 molecules per μg of poly A+ RNA, and these inductions were markedly suppressed by DEX. The results suggest that, during systemic inflammation, iNOS mRNA induction occurs in brain through a DEX-sensitive mechanism.

AB - Systemic administration of lipopolysaccharide (LPS), which causes endotoxemia and systemic inflammation, has been reported to induce expression of the gene for type II inducible nitric oxide synthase (iNOS) in peripheral organs. This study was carried out to examine whether intraperitoneally injected LPS elicits the expression of iNOS messenger ribonucleic acid (mRNA) in the rat brain. We also investigated whether intraperitoneal treatment with dexamethasone (DEX) prevents this induction. To determine levels of iNOS mRNA, a quantitative reverse transcription-polymerase chain reaction (RT-PCR) method was employed. Treatment with LPS induced the expression of iNOS mRNA in various brain regions, accounting for approximately 1 x 105 to 4 x 105 molecules per μg of poly A+ RNA, and these inductions were markedly suppressed by DEX. The results suggest that, during systemic inflammation, iNOS mRNA induction occurs in brain through a DEX-sensitive mechanism.

UR - http://www.scopus.com/inward/record.url?scp=0031009435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031009435&partnerID=8YFLogxK

M3 - Article

C2 - 9074304

AN - SCOPUS:0031009435

VL - 22

SP - 105

EP - 110

JO - Journal of Psychiatry and Neuroscience

JF - Journal of Psychiatry and Neuroscience

SN - 1180-4882

IS - 2

ER -